Atlas Venture Life Science Advisors, LLC Kymera Therapeutics, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $810 Million
- Q3 2024
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 4,896,462 shares of KYMR stock, worth $199 Million. This represents 28.59% of its overall portfolio holdings.
Number of Shares
4,896,462
Previous 5,350,422
8.48%
Holding current value
$199 Million
Previous $160 Million
45.11%
% of portfolio
28.59%
Previous 21.28%
Shares
6 transactions
Others Institutions Holding KYMR
# of Institutions
184Shares Held
64.4MCall Options Held
50.6KPut Options Held
81.7K-
Price T Rowe Associates Inc Baltimore, MD6.65MShares$270 Million0.04% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$244 Million3.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$210 Million7.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.75MShares$193 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.62MShares$188 Million0.04% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.22B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...